Larotrectinib capsules are a breakthrough in oncology, designed for patients with tumors driven by NTRK gene fusions. These targeted therapies inhibit TRK proteins, addressing tumor growth effectively while sparing healthy tissues. Larotrectinib 100 mg in India, offers hope for improved outcomes across various cancer types. Impomed Healthcare takes pride in supplying this innovative therapy, contributing to advancements in personalized cancer care with precision and dedication. For more information Visit:- https://www.impomedhealthcare.com/